$DSNY
DESTINY MEDIA TECHNOLOGIES INC

2022 Q3 Form 10-Q Financial Statement

#000106299322016233 Filed on July 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $990.0K $999.3K $896.4K
YoY Change -3.88% -7.81% -3.68%
Cost Of Revenue $180.0K $209.6K $151.3K
YoY Change 63.64% 114.31% 64.65%
Gross Profit $820.0K $789.7K $745.1K
YoY Change -10.87% -19.93% -11.17%
Gross Profit Margin 82.83% 79.02% 83.12%
Selling, General & Admin $400.0K $432.2K $566.8K
YoY Change -28.57% -23.41% 12.16%
% of Gross Profit 48.78% 54.73% 76.07%
Research & Development $150.0K $326.1K $367.3K
YoY Change -34.78% -0.1% 8.87%
% of Gross Profit 18.29% 41.3% 49.3%
Depreciation & Amortization $50.00K $32.85K $20.00K
YoY Change 66.67% 9.5% -33.33%
% of Gross Profit 6.1% 4.16% 2.68%
Operating Expenses $600.0K $794.6K $960.7K
YoY Change -27.71% -13.39% 10.53%
Operating Profit $220.0K -$4.928K -$215.6K
YoY Change 144.44% -107.17% 610.56%
Interest Expense -$20.00K -$30.00K -$10.00K
YoY Change -25.0% -150.0%
% of Operating Profit -9.09%
Other Income/Expense, Net
YoY Change
Pretax Income $190.0K -$3.242K -$202.6K
YoY Change 111.11% -104.63% 575.37%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $190.0K -$3.242K -$202.6K
YoY Change 111.11% -104.66% 587.61%
Net Earnings / Revenue 19.19% -0.32% -22.6%
Basic Earnings Per Share $0.00 -$0.02
Diluted Earnings Per Share $0.02 $0.00 -$0.02
COMMON SHARES
Basic Shares Outstanding 10.12M shares 10.12M shares 10.21M shares
Diluted Shares Outstanding 10.12M shares 10.21M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.100M $1.950M $2.430M
YoY Change -23.64% -33.45% -19.27%
Cash & Equivalents $2.096M $1.953M $2.434M
Short-Term Investments
Other Short-Term Assets $110.0K $100.0K $80.00K
YoY Change 10.0% 42.86% -20.0%
Inventory
Prepaid Expenses $83.24K $54.94K
Receivables $483.8K $800.8K $410.0K
Other Receivables $29.60K $23.28K $30.00K
Total Short-Term Assets $2.726M $2.878M $2.960M
YoY Change -17.64% -16.59% -14.94%
LONG-TERM ASSETS
Property, Plant & Equipment $311.8K $359.5K $110.0K
YoY Change 117.3% -16.4% -76.6%
Goodwill
YoY Change
Intangibles $529.7K $254.5K
YoY Change 182.33%
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00 $10.00K
YoY Change -100.0% -100.0% -75.0%
Total Long-Term Assets $841.5K $614.0K $440.0K
YoY Change 51.1% 11.63% -15.38%
TOTAL ASSETS
Total Short-Term Assets $2.726M $2.878M $2.960M
Total Long-Term Assets $841.5K $614.0K $440.0K
Total Assets $3.567M $3.492M $3.400M
YoY Change -7.74% -12.71% -15.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $116.3K $116.2K $70.00K
YoY Change -42.64% -17.03% -50.0%
Accrued Expenses $319.7K $301.4K $380.0K
YoY Change 3.19% -52.91% -37.7%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $457.1K $443.1K $450.0K
YoY Change -38.9% -43.91% -40.79%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $457.1K $443.1K $450.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $457.1K $443.1K $450.0K
YoY Change -38.9% -45.97% -48.86%
SHAREHOLDERS EQUITY
Retained Earnings -$5.639M -$5.829M
YoY Change -2.58%
Common Stock $10.12K $10.12K
YoY Change -1.4%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.110M $3.049M $2.951M
YoY Change
Total Liabilities & Shareholders Equity $3.567M $3.492M $3.400M
YoY Change -7.74% -12.71% -15.0%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income $190.0K -$3.242K -$202.6K
YoY Change 111.11% -104.66% 587.61%
Depreciation, Depletion And Amortization $50.00K $32.85K $20.00K
YoY Change 66.67% 9.5% -33.33%
Cash From Operating Activities $530.0K -$290.0K $120.0K
YoY Change 488.89% -680.0% -340.0%
INVESTING ACTIVITIES
Capital Expenditures $310.0K $210.0K $90.00K
YoY Change 181.82% 133.33%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$310.0K -$210.0K -$90.00K
YoY Change 181.82% 133.33% -400.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 -150.0K
YoY Change -100.0% -100.0% 200.0%
NET CHANGE
Cash From Operating Activities 530.0K -290.0K 120.0K
Cash From Investing Activities -310.0K -210.0K -90.00K
Cash From Financing Activities 0.000 0.000 -150.0K
Net Change In Cash 220.0K -500.0K -120.0K
YoY Change -466.67% 138.1% 71.43%
FREE CASH FLOW
Cash From Operating Activities $530.0K -$290.0K $120.0K
Capital Expenditures $310.0K $210.0K $90.00K
Free Cash Flow $220.0K -$500.0K $30.00K
YoY Change -1200.0% 1150.0% -160.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-3242 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
28168 usd
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
149774 usd
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10122261 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10122261 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10265361 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10265361 shares
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
24926 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
219368 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
326450 usd
CY2022Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
326125 usd
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10122261 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10426961 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10122261 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10531708 shares
CY2021Q2 dsny Stock Retired During Period Value
StockRetiredDuringPeriodValue
173678 usd
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Use of Estimates</b></span></span></p> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The preparation of the unaudited condensed consolidated financial statements in accordance with U.S. GAAP requires management to make use of certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reported periods. The Company bases its estimates on historical experience and on various other assumptions that management believes are reasonable under the circumstances, the results of which form the basis for making judgments about carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Significant estimates are related to the recoverability of long-term assets including intangible assets, amortization expense, and valuation of stock-based compensation.</span></span></p> </div>
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
608247 usd
CY2021 dsny Share Based Compensation Arrangement By Share Based Payment Award Options Granted Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue
0 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
561000 shares
dsny Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageRemainingContractualTerm
P2Y25D
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
203750 shares
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.48
CY2022Q2 us-gaap Revenues
Revenues
999282 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
318995 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
113172 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
209605 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
789677 usd
CY2022Q2 us-gaap Revenues
Revenues
999282 usd
CY2021Q2 us-gaap Revenues
Revenues
1083987 usd
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
97804 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
986183 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
202878 usd
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
361411 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
3183379 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
36313 usd
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1686 usd
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
26673 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4928 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
68771 usd
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
823 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
69594 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
3118398 usd
dsny Stock Retired During Period Value
StockRetiredDuringPeriodValue
218682 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
502727 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
39117 usd
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
11275 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
2951099 usd
dsny Share Based Compensation Arrangement By Share Based Payment Award Options Granted Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue
0 usd
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.5
dsny Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm
P5Y
dsny Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrossWeightedAverageGrantDateFairValue
1.5
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
561000 shares
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
463509 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
254489 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
717998 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
36313 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
90059 usd
dsny Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedIntrinsicValue
0 usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
30000 shares
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
26673 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
77388 usd
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
420625 usd
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
187622 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 usd
CY2021Q2 us-gaap Revenues
Revenues
1083987 usd

Files In Submission

Name View Source Status
0001062993-22-016233-index-headers.html Edgar Link pending
0001062993-22-016233-index.html Edgar Link pending
0001062993-22-016233.txt Edgar Link pending
0001062993-22-016233-xbrl.zip Edgar Link pending
dsny-20220531.xsd Edgar Link pending
dsny-20220531_cal.xml Edgar Link unprocessable
dsny-20220531_def.xml Edgar Link unprocessable
dsny-20220531_lab.xml Edgar Link unprocessable
dsny-20220531_pre.xml Edgar Link unprocessable
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10q.htm Edgar Link pending
form10q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending